SlideShare a Scribd company logo
ANTIBIOTICS
• Antibiotics can be defined as substances
capable of killing & inhibiting the growth of
micro organisms.
• The term antibiotics literally means “against
life”; in this case, against microbes.
• There are many types of antibiotics—
antibacterials, antivirals, antifungals, and
antiparasitics.
4Con…
COMMON BACTERIA BY SITE OF INFECTION
Classifications of Antibiotics
Classifications of Antibiotics
Spectrum of
activity
Broad
spectrum
Narrow
spectrum
Site of action
Type of
action
Bacteriostatic Bactericidal
1. Mechanism of action
2. Mode of action
• Bacteriostatic vs. bactericidal drugs;
• Bacteriostatic
– arrest the growth and replication of bacteria at
serum levels achievable in the patient.
– limit the spread of infection while the body's immune
system attacks, immobilizes, and eliminates the
pathogens.
– If the drug is removed before the immune system has
scavenged the organisms, enough viable organisms
may remain to begin a second cycle of infection.
• Bactericidal
– kill bacteria at drug serum levels achievable in the
patient. - often drugs of choice in seriously ill
patients.
• It is possible for ATB to be bacteriostatic for
one organism and bactericidal for another.
2. Mode of action
2. Type of action
3. Spectrum of activity
• Narrow spectrum
• only against a single or a limited group of
microorganisms,
• e.g. INH is active only against mycobacteria.
• Broad spectrum
• affect a wide variety of microbial species.
• e.g. tetracycline and chloramphenicol
• Alter the normal bacterial flora ????
• precipitate a superinfection of an organism, e.g.,
candida.
3. Spectrum of activity
Drug resistance
• Growth of bacteria is not halted by the maximal level of
that antibiotic that can be tolerated by the host.
 Primary
 Some organisms are inherently resistant to an antibiotic
 e.g., gram-negative organisms are inherently resistant to
vancomycin.
 Secondary
 spontaneous mutation or acquired resistance and selection.
 Cross-resistance
 resistant to more than one antibiotic.
Drug resistance
• Factors that may contribute to the
emergence and dissemination of
antimicrobial resistance
o ► Inadequate infection control
o ► High antimicrobial usage per geographic
area per unit time
o ► Increased use of antimicrobial prophylaxis
o ► Increased empiric polymicrobial
antimicrobial therapy.
o ► Greater severity of illness of hospitalized
patients
o ► More severely immunocompromised patients
o ► Newer devices and procedures in use
o ► Agricultural use of antimicrobials
o ► Social factors
o ► International travel
o ► Evolution of pathogens
Drug resistance
Facing the End of the Antibiotic Era
• Very few new
antibiotics during past
30 years
• More toxic antibiotics
being used to treat
common infections
• Future currently not
looking very promising
What is Misuse of Antibiotics?:
• When antibiotics are prescribed unnecessarily;
• When antibiotic administration is delayed in
critically ill patients;
• When antibiotic treatment is not given according
to microbiological culture data results.
• When the dose is lower or higher than
appropriate for the specific patient; and route of
administrations [IV vs. oral] not appropriate
• When the duration of treatment is too short or
too long;
Inappropriate prescription
• CDC estimates more than two million people are
infected with antibiotic-resistant organisms, resulting in
approximately 23,000 deaths annually.
• “Antibiotic resistance comes mainly because of
inappropriate or improper use of antibiotics by
physicians. Some 150 million prescriptions are written
annually in this country. And 60 percent of them —
that translates to 90 million prescriptions — are for
antibiotics. Of those, 50 million are absolutely
unnecessary or inappropriate”.
— Dr. Philip Tierno, director of clinical microbiology and diagnostic
immunology at New York University Medical Center
Stewardship Programs
• Is an organized antimicrobial management
program that can be undertaken to improve
antimicrobial usage in order to achieve
optimal outcomes to cure or prevent
infection, and while minimizing toxicity and
emergence of resistance.
• Antibiotic stewardship ensures that the patient
only receives an antibiotic when needed AND the
right drug, dose, and duration is prescribed
• In 2014,CDC recommends that all hospitals
should have antimicrobial stewardship programs
• Programs will look different in various hospitals,
depending on the size and complexity of the
patient population
Stewardship Team
Antimicrobial stewardship is the 8 R’s:
• Right drug,
• Right time
• Right dose
• Right route
• Right Resident
• Right Documentation
• Right Reason
• Right Response
• Right drug
– Check the medication label, check the order
• Right time
– Check the frequency of ordered medication
– Confirm when last dose was given
• Right dose
• Right route
– Check order for appropriateness of route
ordered(IV/IM/oral)
– Confirm resident can take or receive med by
the ordered route
• Right resident
– Check name on the order and the resident
• Right documentation
– Document administration after giving med
– Chart the time, route, and other necessary
information
• Right reason
why medication ordered
• Right response
– Desired response achieved
Goals of Antibiotic
Stewardship Programs
1. Reduce antibiotic consumption and
inappropriate us
2. Improve patient outcomes & decrease
morbidity and mortality
3. Increase adherence/utilization of
treatment guidelines
4. Reduce adverse drug events
5. Decrease or limit antibiotic resistance
6. reduce healthcare costs
Why Stewardship
Classification of Antibiotic According
to steward ship program
• A-Green flag : prescribed by all doctors
• Amoxil, ampicilline,Ampiclox,
• Gentamycine, Amikacin
• Aciclovir IV
• Ceftriaxone / Cefotaxime
• Clarithromycin
• Amikacin
• Azithromycin
• Keflex,cefixim and others…..etc
which can be prescribed with the permission of infectious disease
comitte
• Vancomycin
• meropenem,imipeme
m,cefepime,
• levofloxacine
• Itraconazole
• levofloxacine
• Piperacillin +
Tazobactam (Tazocin®)
• Ribavirin
• Teicoplanin
• Terbinafine
• Ticarcillin + Clavulanate
(Timentin)
• Valganciclovir
• Fluconazole IV
• Sodium Fusidate
B-Orange flag continue
C-Red flag:
• Used only by infectious disease doctors (consultant)
• linezolid,
• daptomycin,
• colistin,
• Amphotericin ,
• Caspofungin,
• Moxifloxacin,
• Pristinamycin
• Tigecycline,
• Voriconazole
Duhok Stewardship Team
Dr.Nawfal
Rasheed
Hussein
Shameran
Slewa Daniel
Sulaf khorshed
adil
Azad A. Haleem Heevi
hospital
Nawzad Sulaeman
Murad. Emergency
Hospital
Ayid Murad Qasim
Azadi Hospital
Bayram Dawod
Ahmed
Heevi pediatric hospital
Dr.name
Sep-2016 Jan 2017
Patients NO. % Patients NO. %
Dr.Mahdeya 64 50% 83 30%
Dr.Nzar 120 43% 113 38%
Dr.Khalid Barware 34 95% 40 66%
Dr.Ahmeed Ezat 70 54% 67 37%
Dr.Salah 52 55% 95 53%
Dr.Nader 90 40% 118 44%
Dr.Azad 80 40% 90 47%
Dr.Akram Atroshe 56 41% 63 39%
Dr.Sardar 34 50% 37 55%
Dr.Akram Ismaeel 60 43% 53 40%
10 Doctors 660 51% 759 45%
By:Dr.sulaf Khorsheed Adel
Antibiotic  Resistance & stewardship program in children

More Related Content

What's hot

Newer vaccine new ppt
Newer vaccine new pptNewer vaccine new ppt
Newer vaccine new ppt
Wal
 
immunization in special situations
immunization in special situationsimmunization in special situations
immunization in special situationsNupur Sinha
 
Bcg opv ipv vaccines and catchup vaccination (immunization)
Bcg opv ipv vaccines and catchup vaccination (immunization)Bcg opv ipv vaccines and catchup vaccination (immunization)
Bcg opv ipv vaccines and catchup vaccination (immunization)
Praveen RK
 
Rota virus vaccine
Rota virus vaccineRota virus vaccine
Rota virus vaccine
swati shikha
 
Hepatitis Viral Markers
Hepatitis Viral MarkersHepatitis Viral Markers
Hepatitis Viral Markers
Waleed El-Refaey
 
Campaign to prevent antimicrobial resistance
Campaign to prevent antimicrobial resistanceCampaign to prevent antimicrobial resistance
Campaign to prevent antimicrobial resistance
guest3008cc
 
Adverse events following immunisation
Adverse events following immunisationAdverse events following immunisation
Adverse events following immunisation
Dr Bushra Jabeen
 
CBNAAT
CBNAATCBNAAT
CBNAAT
Ankur Gupta
 
Adverse events fallowing immunization
Adverse events fallowing immunizationAdverse events fallowing immunization
Adverse events fallowing immunization
devika Pj
 
Managment of Resistant Gram Negative Infections
Managment of Resistant Gram Negative InfectionsManagment of Resistant Gram Negative Infections
Managment of Resistant Gram Negative Infections
Yazan Kherallah
 
Management of Hepatitis B
Management of Hepatitis BManagement of Hepatitis B
Management of Hepatitis B
Arun Vasireddy
 
Tuberculosis & hiv coexistence
Tuberculosis & hiv coexistenceTuberculosis & hiv coexistence
Tuberculosis & hiv coexistence
Dr. Kanwal Deep Singh Lyall
 
Meningitis Vaccines
Meningitis VaccinesMeningitis Vaccines
Meningitis Vaccines
Meningitis Research Foundation
 
Vaccine preventable diseases
Vaccine preventable diseasesVaccine preventable diseases
Vaccine preventable diseases
Dr. Eman M. Mortada
 
IDSA Practice Guidelines for Antimicrobial Stewardship Programs
IDSA Practice Guidelines for Antimicrobial Stewardship ProgramsIDSA Practice Guidelines for Antimicrobial Stewardship Programs
IDSA Practice Guidelines for Antimicrobial Stewardship Programs
Joy Awoniyi
 
AEFI -Adverse event following immunization by Dr. Sonam Aggarwal
AEFI -Adverse event following immunization by Dr. Sonam AggarwalAEFI -Adverse event following immunization by Dr. Sonam Aggarwal
AEFI -Adverse event following immunization by Dr. Sonam Aggarwal
Dr. Sonam Aggarwal
 
Recurrent or Persistent Pneumonia
Recurrent or Persistent PneumoniaRecurrent or Persistent Pneumonia
Recurrent or Persistent Pneumonia
Keshav Chandra
 
Pediatrics pharmacology: Antibiotics
Pediatrics pharmacology: AntibioticsPediatrics pharmacology: Antibiotics
Pediatrics pharmacology: Antibiotics
Azad Haleem
 
Catch up vaccine
Catch up vaccineCatch up vaccine
Catch up vaccinestudent
 

What's hot (20)

Newer vaccine new ppt
Newer vaccine new pptNewer vaccine new ppt
Newer vaccine new ppt
 
immunization in special situations
immunization in special situationsimmunization in special situations
immunization in special situations
 
Bcg opv ipv vaccines and catchup vaccination (immunization)
Bcg opv ipv vaccines and catchup vaccination (immunization)Bcg opv ipv vaccines and catchup vaccination (immunization)
Bcg opv ipv vaccines and catchup vaccination (immunization)
 
Rota virus vaccine
Rota virus vaccineRota virus vaccine
Rota virus vaccine
 
Pneumococcal vaccines
Pneumococcal vaccinesPneumococcal vaccines
Pneumococcal vaccines
 
Hepatitis Viral Markers
Hepatitis Viral MarkersHepatitis Viral Markers
Hepatitis Viral Markers
 
Campaign to prevent antimicrobial resistance
Campaign to prevent antimicrobial resistanceCampaign to prevent antimicrobial resistance
Campaign to prevent antimicrobial resistance
 
Adverse events following immunisation
Adverse events following immunisationAdverse events following immunisation
Adverse events following immunisation
 
CBNAAT
CBNAATCBNAAT
CBNAAT
 
Adverse events fallowing immunization
Adverse events fallowing immunizationAdverse events fallowing immunization
Adverse events fallowing immunization
 
Managment of Resistant Gram Negative Infections
Managment of Resistant Gram Negative InfectionsManagment of Resistant Gram Negative Infections
Managment of Resistant Gram Negative Infections
 
Management of Hepatitis B
Management of Hepatitis BManagement of Hepatitis B
Management of Hepatitis B
 
Tuberculosis & hiv coexistence
Tuberculosis & hiv coexistenceTuberculosis & hiv coexistence
Tuberculosis & hiv coexistence
 
Meningitis Vaccines
Meningitis VaccinesMeningitis Vaccines
Meningitis Vaccines
 
Vaccine preventable diseases
Vaccine preventable diseasesVaccine preventable diseases
Vaccine preventable diseases
 
IDSA Practice Guidelines for Antimicrobial Stewardship Programs
IDSA Practice Guidelines for Antimicrobial Stewardship ProgramsIDSA Practice Guidelines for Antimicrobial Stewardship Programs
IDSA Practice Guidelines for Antimicrobial Stewardship Programs
 
AEFI -Adverse event following immunization by Dr. Sonam Aggarwal
AEFI -Adverse event following immunization by Dr. Sonam AggarwalAEFI -Adverse event following immunization by Dr. Sonam Aggarwal
AEFI -Adverse event following immunization by Dr. Sonam Aggarwal
 
Recurrent or Persistent Pneumonia
Recurrent or Persistent PneumoniaRecurrent or Persistent Pneumonia
Recurrent or Persistent Pneumonia
 
Pediatrics pharmacology: Antibiotics
Pediatrics pharmacology: AntibioticsPediatrics pharmacology: Antibiotics
Pediatrics pharmacology: Antibiotics
 
Catch up vaccine
Catch up vaccineCatch up vaccine
Catch up vaccine
 

Similar to Antibiotic Resistance & stewardship program in children

Antibiotic; introduction & stewardship program in children
Antibiotic; introduction & stewardship program in childrenAntibiotic; introduction & stewardship program in children
Antibiotic; introduction & stewardship program in children
Azad Haleem
 
AB policy.pptx
AB policy.pptxAB policy.pptx
AB policy.pptx
AhmedMandour37
 
Antibiotic Policy.pdf
Antibiotic Policy.pdfAntibiotic Policy.pdf
Antibiotic Policy.pdf
AhmedSamir462624
 
Antibiotic stewardship program in children
Antibiotic stewardship program in childrenAntibiotic stewardship program in children
Antibiotic stewardship program in children
Azad Haleem
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
wisam alsaedi
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
Mona Mustafa
 
Anti microbial resistance
Anti microbial resistanceAnti microbial resistance
Anti microbial resistance
OKELLO ISAAC OPIO
 
Infection Control and Antibiotic resistance
Infection Control and Antibiotic resistanceInfection Control and Antibiotic resistance
Infection Control and Antibiotic resistance
Moustapha Ramadan
 
ANTIBIOTIC POLICY.pptx
ANTIBIOTIC POLICY.pptxANTIBIOTIC POLICY.pptx
ANTIBIOTIC POLICY.pptx
Monishabasavaraj
 
Chp no 2 anti-microbial.pptx
Chp no 2 anti-microbial.pptxChp no 2 anti-microbial.pptx
Chp no 2 anti-microbial.pptx
MahnoorFatima92
 
ANTIBIOTIC POLICY.pptx
ANTIBIOTIC POLICY.pptxANTIBIOTIC POLICY.pptx
ANTIBIOTIC POLICY.pptx
Monishabasavaraj
 
1. ANTIBIOTICS.ppt
1. ANTIBIOTICS.ppt1. ANTIBIOTICS.ppt
1. ANTIBIOTICS.ppt
CephasKhediraMtimauk
 
antibioticsuseinsurgery-200130112606.pptx
antibioticsuseinsurgery-200130112606.pptxantibioticsuseinsurgery-200130112606.pptx
antibioticsuseinsurgery-200130112606.pptx
RebumaMegersa1
 
Principles of antimicrobial (1)
Principles of antimicrobial (1)Principles of antimicrobial (1)
Principles of antimicrobial (1)
Zainab&Sons
 
Principle of antibiotic use.pptx
Principle of antibiotic use.pptxPrinciple of antibiotic use.pptx
Principle of antibiotic use.pptx
Olofin Kayode
 
Antimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptxAntimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptx
Dr. Kiran Dhamak
 
Rational use of antibiotics
Rational use of antibioticsRational use of antibiotics
Rational use of antibiotics
ZeelNaik2
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
Antimicrobial Stewardship
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial Stewardship
Santoshkumar Biradar
 
Rational drug use
Rational drug useRational drug use
Rational drug use
velspharmd
 

Similar to Antibiotic Resistance & stewardship program in children (20)

Antibiotic; introduction & stewardship program in children
Antibiotic; introduction & stewardship program in childrenAntibiotic; introduction & stewardship program in children
Antibiotic; introduction & stewardship program in children
 
AB policy.pptx
AB policy.pptxAB policy.pptx
AB policy.pptx
 
Antibiotic Policy.pdf
Antibiotic Policy.pdfAntibiotic Policy.pdf
Antibiotic Policy.pdf
 
Antibiotic stewardship program in children
Antibiotic stewardship program in childrenAntibiotic stewardship program in children
Antibiotic stewardship program in children
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
 
Anti microbial resistance
Anti microbial resistanceAnti microbial resistance
Anti microbial resistance
 
Infection Control and Antibiotic resistance
Infection Control and Antibiotic resistanceInfection Control and Antibiotic resistance
Infection Control and Antibiotic resistance
 
ANTIBIOTIC POLICY.pptx
ANTIBIOTIC POLICY.pptxANTIBIOTIC POLICY.pptx
ANTIBIOTIC POLICY.pptx
 
Chp no 2 anti-microbial.pptx
Chp no 2 anti-microbial.pptxChp no 2 anti-microbial.pptx
Chp no 2 anti-microbial.pptx
 
ANTIBIOTIC POLICY.pptx
ANTIBIOTIC POLICY.pptxANTIBIOTIC POLICY.pptx
ANTIBIOTIC POLICY.pptx
 
1. ANTIBIOTICS.ppt
1. ANTIBIOTICS.ppt1. ANTIBIOTICS.ppt
1. ANTIBIOTICS.ppt
 
antibioticsuseinsurgery-200130112606.pptx
antibioticsuseinsurgery-200130112606.pptxantibioticsuseinsurgery-200130112606.pptx
antibioticsuseinsurgery-200130112606.pptx
 
Principles of antimicrobial (1)
Principles of antimicrobial (1)Principles of antimicrobial (1)
Principles of antimicrobial (1)
 
Principle of antibiotic use.pptx
Principle of antibiotic use.pptxPrinciple of antibiotic use.pptx
Principle of antibiotic use.pptx
 
Antimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptxAntimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptx
 
Rational use of antibiotics
Rational use of antibioticsRational use of antibiotics
Rational use of antibiotics
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
Antimicrobial Stewardship
Antimicrobial StewardshipAntimicrobial Stewardship
Antimicrobial Stewardship
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 

More from Azad Haleem

Climate change, the environment, and rhinologic disease .pptx
Climate change, the environment, and rhinologic disease .pptxClimate change, the environment, and rhinologic disease .pptx
Climate change, the environment, and rhinologic disease .pptx
Azad Haleem
 
Crimean-Congo hemorrhagic fever (CCHF) Approach
Crimean-Congo hemorrhagic fever (CCHF) ApproachCrimean-Congo hemorrhagic fever (CCHF) Approach
Crimean-Congo hemorrhagic fever (CCHF) Approach
Azad Haleem
 
Precocious Puberty in Girl approach and Management
Precocious Puberty in Girl approach and ManagementPrecocious Puberty in Girl approach and Management
Precocious Puberty in Girl approach and Management
Azad Haleem
 
Diagnosis & Management of Hypoglycemia in Children
Diagnosis & Management of Hypoglycemia in ChildrenDiagnosis & Management of Hypoglycemia in Children
Diagnosis & Management of Hypoglycemia in Children
Azad Haleem
 
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Pediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptxPediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptx
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Azad Haleem
 
Neonatal Hypoglycemia approach and Management .pptx
Neonatal Hypoglycemia approach and Management .pptxNeonatal Hypoglycemia approach and Management .pptx
Neonatal Hypoglycemia approach and Management .pptx
Azad Haleem
 
Preterm infants Nutrition .pptx
Preterm infants Nutrition .pptxPreterm infants Nutrition .pptx
Preterm infants Nutrition .pptx
Azad Haleem
 
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptxPreterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Azad Haleem
 
Breastfeeding VS formula feeding .pptx
 Breastfeeding VS formula feeding .pptx Breastfeeding VS formula feeding .pptx
Breastfeeding VS formula feeding .pptx
Azad Haleem
 
Role of Supplements in Growth Failure in Children .pptx
Role of Supplements in Growth Failure in Children .pptxRole of Supplements in Growth Failure in Children .pptx
Role of Supplements in Growth Failure in Children .pptx
Azad Haleem
 
Degludec Insulin therapy in children
Degludec Insulin therapy in childrenDegludec Insulin therapy in children
Degludec Insulin therapy in children
Azad Haleem
 
Viral hemorrhagic fevers.pptx
Viral hemorrhagic fevers.pptxViral hemorrhagic fevers.pptx
Viral hemorrhagic fevers.pptx
Azad Haleem
 
Micronutrient deficiencies in children .pptx
 Micronutrient deficiencies in children  .pptx Micronutrient deficiencies in children  .pptx
Micronutrient deficiencies in children .pptx
Azad Haleem
 
Insulin therapy in children.pptx
Insulin therapy in children.pptxInsulin therapy in children.pptx
Insulin therapy in children.pptx
Azad Haleem
 
Diagnostic test for testicular and ovarian disorders in children 2.pptx
Diagnostic test for testicular and ovarian disorders in children 2.pptxDiagnostic test for testicular and ovarian disorders in children 2.pptx
Diagnostic test for testicular and ovarian disorders in children 2.pptx
Azad Haleem
 
Diagnostic test for Adrenal disorders in children 2.pptx
Diagnostic test for Adrenal disorders in children 2.pptxDiagnostic test for Adrenal disorders in children 2.pptx
Diagnostic test for Adrenal disorders in children 2.pptx
Azad Haleem
 
Diagnostic test for Thyriod disorders in children.pptx
Diagnostic test for Thyriod disorders in children.pptxDiagnostic test for Thyriod disorders in children.pptx
Diagnostic test for Thyriod disorders in children.pptx
Azad Haleem
 
Achondroplasia in children.pptx
Achondroplasia in children.pptxAchondroplasia in children.pptx
Achondroplasia in children.pptx
Azad Haleem
 
Growth failure in Children.pptx
Growth failure in Children.pptxGrowth failure in Children.pptx
Growth failure in Children.pptx
Azad Haleem
 
Adenoid Enlargement in children.pptx
Adenoid Enlargement in children.pptxAdenoid Enlargement in children.pptx
Adenoid Enlargement in children.pptx
Azad Haleem
 

More from Azad Haleem (20)

Climate change, the environment, and rhinologic disease .pptx
Climate change, the environment, and rhinologic disease .pptxClimate change, the environment, and rhinologic disease .pptx
Climate change, the environment, and rhinologic disease .pptx
 
Crimean-Congo hemorrhagic fever (CCHF) Approach
Crimean-Congo hemorrhagic fever (CCHF) ApproachCrimean-Congo hemorrhagic fever (CCHF) Approach
Crimean-Congo hemorrhagic fever (CCHF) Approach
 
Precocious Puberty in Girl approach and Management
Precocious Puberty in Girl approach and ManagementPrecocious Puberty in Girl approach and Management
Precocious Puberty in Girl approach and Management
 
Diagnosis & Management of Hypoglycemia in Children
Diagnosis & Management of Hypoglycemia in ChildrenDiagnosis & Management of Hypoglycemia in Children
Diagnosis & Management of Hypoglycemia in Children
 
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Pediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptxPediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptx
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
 
Neonatal Hypoglycemia approach and Management .pptx
Neonatal Hypoglycemia approach and Management .pptxNeonatal Hypoglycemia approach and Management .pptx
Neonatal Hypoglycemia approach and Management .pptx
 
Preterm infants Nutrition .pptx
Preterm infants Nutrition .pptxPreterm infants Nutrition .pptx
Preterm infants Nutrition .pptx
 
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptxPreterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
Preterm : ABCDE; approach to nutritional assessment in preterm infants.pptx
 
Breastfeeding VS formula feeding .pptx
 Breastfeeding VS formula feeding .pptx Breastfeeding VS formula feeding .pptx
Breastfeeding VS formula feeding .pptx
 
Role of Supplements in Growth Failure in Children .pptx
Role of Supplements in Growth Failure in Children .pptxRole of Supplements in Growth Failure in Children .pptx
Role of Supplements in Growth Failure in Children .pptx
 
Degludec Insulin therapy in children
Degludec Insulin therapy in childrenDegludec Insulin therapy in children
Degludec Insulin therapy in children
 
Viral hemorrhagic fevers.pptx
Viral hemorrhagic fevers.pptxViral hemorrhagic fevers.pptx
Viral hemorrhagic fevers.pptx
 
Micronutrient deficiencies in children .pptx
 Micronutrient deficiencies in children  .pptx Micronutrient deficiencies in children  .pptx
Micronutrient deficiencies in children .pptx
 
Insulin therapy in children.pptx
Insulin therapy in children.pptxInsulin therapy in children.pptx
Insulin therapy in children.pptx
 
Diagnostic test for testicular and ovarian disorders in children 2.pptx
Diagnostic test for testicular and ovarian disorders in children 2.pptxDiagnostic test for testicular and ovarian disorders in children 2.pptx
Diagnostic test for testicular and ovarian disorders in children 2.pptx
 
Diagnostic test for Adrenal disorders in children 2.pptx
Diagnostic test for Adrenal disorders in children 2.pptxDiagnostic test for Adrenal disorders in children 2.pptx
Diagnostic test for Adrenal disorders in children 2.pptx
 
Diagnostic test for Thyriod disorders in children.pptx
Diagnostic test for Thyriod disorders in children.pptxDiagnostic test for Thyriod disorders in children.pptx
Diagnostic test for Thyriod disorders in children.pptx
 
Achondroplasia in children.pptx
Achondroplasia in children.pptxAchondroplasia in children.pptx
Achondroplasia in children.pptx
 
Growth failure in Children.pptx
Growth failure in Children.pptxGrowth failure in Children.pptx
Growth failure in Children.pptx
 
Adenoid Enlargement in children.pptx
Adenoid Enlargement in children.pptxAdenoid Enlargement in children.pptx
Adenoid Enlargement in children.pptx
 

Recently uploaded

Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
Mohammed Sikander
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
DhatriParmar
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 

Recently uploaded (20)

Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Multithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race conditionMultithreading_in_C++ - std::thread, race condition
Multithreading_in_C++ - std::thread, race condition
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
The Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptxThe Diamond Necklace by Guy De Maupassant.pptx
The Diamond Necklace by Guy De Maupassant.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 

Antibiotic Resistance & stewardship program in children

  • 1.
  • 2.
  • 3. ANTIBIOTICS • Antibiotics can be defined as substances capable of killing & inhibiting the growth of micro organisms. • The term antibiotics literally means “against life”; in this case, against microbes. • There are many types of antibiotics— antibacterials, antivirals, antifungals, and antiparasitics.
  • 4. 4Con… COMMON BACTERIA BY SITE OF INFECTION
  • 5. Classifications of Antibiotics Classifications of Antibiotics Spectrum of activity Broad spectrum Narrow spectrum Site of action Type of action Bacteriostatic Bactericidal
  • 7. 2. Mode of action • Bacteriostatic vs. bactericidal drugs; • Bacteriostatic – arrest the growth and replication of bacteria at serum levels achievable in the patient. – limit the spread of infection while the body's immune system attacks, immobilizes, and eliminates the pathogens. – If the drug is removed before the immune system has scavenged the organisms, enough viable organisms may remain to begin a second cycle of infection.
  • 8. • Bactericidal – kill bacteria at drug serum levels achievable in the patient. - often drugs of choice in seriously ill patients. • It is possible for ATB to be bacteriostatic for one organism and bactericidal for another. 2. Mode of action
  • 9. 2. Type of action
  • 10. 3. Spectrum of activity • Narrow spectrum • only against a single or a limited group of microorganisms, • e.g. INH is active only against mycobacteria. • Broad spectrum • affect a wide variety of microbial species. • e.g. tetracycline and chloramphenicol • Alter the normal bacterial flora ???? • precipitate a superinfection of an organism, e.g., candida.
  • 11. 3. Spectrum of activity
  • 12. Drug resistance • Growth of bacteria is not halted by the maximal level of that antibiotic that can be tolerated by the host.  Primary  Some organisms are inherently resistant to an antibiotic  e.g., gram-negative organisms are inherently resistant to vancomycin.  Secondary  spontaneous mutation or acquired resistance and selection.  Cross-resistance  resistant to more than one antibiotic.
  • 13. Drug resistance • Factors that may contribute to the emergence and dissemination of antimicrobial resistance o ► Inadequate infection control o ► High antimicrobial usage per geographic area per unit time o ► Increased use of antimicrobial prophylaxis o ► Increased empiric polymicrobial antimicrobial therapy.
  • 14. o ► Greater severity of illness of hospitalized patients o ► More severely immunocompromised patients o ► Newer devices and procedures in use o ► Agricultural use of antimicrobials o ► Social factors o ► International travel o ► Evolution of pathogens Drug resistance
  • 15. Facing the End of the Antibiotic Era • Very few new antibiotics during past 30 years • More toxic antibiotics being used to treat common infections • Future currently not looking very promising
  • 16. What is Misuse of Antibiotics?: • When antibiotics are prescribed unnecessarily; • When antibiotic administration is delayed in critically ill patients; • When antibiotic treatment is not given according to microbiological culture data results. • When the dose is lower or higher than appropriate for the specific patient; and route of administrations [IV vs. oral] not appropriate • When the duration of treatment is too short or too long;
  • 17. Inappropriate prescription • CDC estimates more than two million people are infected with antibiotic-resistant organisms, resulting in approximately 23,000 deaths annually. • “Antibiotic resistance comes mainly because of inappropriate or improper use of antibiotics by physicians. Some 150 million prescriptions are written annually in this country. And 60 percent of them — that translates to 90 million prescriptions — are for antibiotics. Of those, 50 million are absolutely unnecessary or inappropriate”. — Dr. Philip Tierno, director of clinical microbiology and diagnostic immunology at New York University Medical Center
  • 18. Stewardship Programs • Is an organized antimicrobial management program that can be undertaken to improve antimicrobial usage in order to achieve optimal outcomes to cure or prevent infection, and while minimizing toxicity and emergence of resistance.
  • 19. • Antibiotic stewardship ensures that the patient only receives an antibiotic when needed AND the right drug, dose, and duration is prescribed • In 2014,CDC recommends that all hospitals should have antimicrobial stewardship programs • Programs will look different in various hospitals, depending on the size and complexity of the patient population
  • 21. Antimicrobial stewardship is the 8 R’s: • Right drug, • Right time • Right dose • Right route • Right Resident • Right Documentation • Right Reason • Right Response
  • 22. • Right drug – Check the medication label, check the order • Right time – Check the frequency of ordered medication – Confirm when last dose was given • Right dose
  • 23. • Right route – Check order for appropriateness of route ordered(IV/IM/oral) – Confirm resident can take or receive med by the ordered route • Right resident – Check name on the order and the resident
  • 24. • Right documentation – Document administration after giving med – Chart the time, route, and other necessary information • Right reason why medication ordered • Right response – Desired response achieved
  • 25. Goals of Antibiotic Stewardship Programs 1. Reduce antibiotic consumption and inappropriate us 2. Improve patient outcomes & decrease morbidity and mortality 3. Increase adherence/utilization of treatment guidelines 4. Reduce adverse drug events 5. Decrease or limit antibiotic resistance 6. reduce healthcare costs
  • 27. Classification of Antibiotic According to steward ship program • A-Green flag : prescribed by all doctors • Amoxil, ampicilline,Ampiclox, • Gentamycine, Amikacin • Aciclovir IV • Ceftriaxone / Cefotaxime • Clarithromycin • Amikacin • Azithromycin • Keflex,cefixim and others…..etc
  • 28. which can be prescribed with the permission of infectious disease comitte • Vancomycin • meropenem,imipeme m,cefepime, • levofloxacine • Itraconazole • levofloxacine • Piperacillin + Tazobactam (Tazocin®) • Ribavirin • Teicoplanin • Terbinafine • Ticarcillin + Clavulanate (Timentin) • Valganciclovir • Fluconazole IV • Sodium Fusidate B-Orange flag continue
  • 29. C-Red flag: • Used only by infectious disease doctors (consultant) • linezolid, • daptomycin, • colistin, • Amphotericin , • Caspofungin, • Moxifloxacin, • Pristinamycin • Tigecycline, • Voriconazole
  • 30. Duhok Stewardship Team Dr.Nawfal Rasheed Hussein Shameran Slewa Daniel Sulaf khorshed adil Azad A. Haleem Heevi hospital Nawzad Sulaeman Murad. Emergency Hospital Ayid Murad Qasim Azadi Hospital Bayram Dawod Ahmed
  • 31. Heevi pediatric hospital Dr.name Sep-2016 Jan 2017 Patients NO. % Patients NO. % Dr.Mahdeya 64 50% 83 30% Dr.Nzar 120 43% 113 38% Dr.Khalid Barware 34 95% 40 66% Dr.Ahmeed Ezat 70 54% 67 37% Dr.Salah 52 55% 95 53% Dr.Nader 90 40% 118 44% Dr.Azad 80 40% 90 47% Dr.Akram Atroshe 56 41% 63 39% Dr.Sardar 34 50% 37 55% Dr.Akram Ismaeel 60 43% 53 40% 10 Doctors 660 51% 759 45% By:Dr.sulaf Khorsheed Adel